1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-0659
  5. NDC Package Code: 70518-0659-1 Ceftriaxone Sodium

NDC Package 70518-0659-1 Ceftriaxone Sodium

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-0659-1
Package Description:
10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (70518-0659-0)
Product Code:
70518-0659
Proprietary Name:
Ceftriaxone Sodium
Usage Information:
Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing.To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, USP and other antibacterial drugs, ceftriaxone for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.Ceftriaxone for injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms:
11-Digit NDC Billing Format:
70518065901
Labeler Name:
Remedyrepack Inc.
Sample Package:
No
FDA Application Number:
ANDA065169
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
08-02-2017
End Marketing Date:
01-13-2023
Listing Expiration Date:
01-13-2023
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70518-0659-1?

The NDC Packaged Code 70518-0659-1 is assigned to a package of 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use (70518-0659-0) of Ceftriaxone Sodium, labeled by Remedyrepack Inc.. The product's dosage form is and is administered via form.

Is NDC 70518-0659 included in the NDC Directory?

No, Ceftriaxone Sodium with product code 70518-0659 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Remedyrepack Inc. on August 02, 2017 and its listing in the NDC Directory is set to expire on January 13, 2023 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70518-0659-1?

The 11-digit format is 70518065901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170518-0659-15-4-270518-0659-01